The price-to-earnings ratio for GE HealthCare Technologies Inc (NASDAQ: GEHC) is above average at 25.92x. The 36-month beta value for GEHC is also noteworthy at 1.38. There are mixed opinions on the stock, with 8 analysts rating it as a “buy,” 4 rating it as “overweight,” 7 rating it as “hold,” and 0 rating it as “sell.”
The public float for GEHC is 424.97M, and at present, short sellers hold a 2.72% of that float. The average trading volume of GEHC on October 23, 2024 was 2.79M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GEHC) stock’s latest price update
The stock price of GE HealthCare Technologies Inc (NASDAQ: GEHC) has plunged by -0.55 when compared to previous closing price of 89.80, but the company has seen a -1.54% decline in its stock price over the last five trading sessions. zacks.com reported 2024-10-22 that GE Healthcare announces CareIntellect for Oncology to provide multi-modal patient data from disparate systems into a single view using generative AI.
GEHC’s Market Performance
GE HealthCare Technologies Inc (GEHC) has seen a -1.54% fall in stock performance for the week, with a -1.73% decline in the past month and a 12.07% surge in the past quarter. The volatility ratio for the week is 1.61%, and the volatility levels for the past 30 days are at 1.83% for GEHC. The simple moving average for the past 20 days is -1.96% for GEHC’s stock, with a 6.76% simple moving average for the past 200 days.
Analysts’ Opinion of GEHC
Many brokerage firms have already submitted their reports for GEHC stocks, with UBS repeating the rating for GEHC by listing it as a “Sell.” The predicted price for GEHC in the upcoming period, according to UBS is $74 based on the research report published on September 26, 2024 of the current year 2024.
BTIG Research, on the other hand, stated in their research note that they expect to see GEHC reach a price target of $100. The rating they have provided for GEHC stocks is “Buy” according to the report published on September 18th, 2024.
JP Morgan gave a rating of “Neutral” to GEHC, setting the target price at $90 in the report published on September 09th of the current year.
GEHC Trading at 1.32% from the 50-Day Moving Average
After a stumble in the market that brought GEHC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -5.54% of loss for the given period.
Volatility was left at 1.83%, however, over the last 30 days, the volatility rate increased by 1.61%, as shares sank -3.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +8.43% upper at present.
During the last 5 trading sessions, GEHC fell by -1.54%, which changed the moving average for the period of 200-days by +16.56% in comparison to the 20-day moving average, which settled at $91.10. In addition, GE HealthCare Technologies Inc saw 15.51% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at GEHC starting from Stacherski Kenneth R., who sale 19,008 shares at the price of $83.22 back on Aug 14 ’24. After this action, Stacherski Kenneth R. now owns 38,541 shares of GE HealthCare Technologies Inc, valued at $1,581,846 using the latest closing price.
Kenneth Stacherski, the Officer of GE HealthCare Technologies Inc, proposed sale 19,008 shares at $82.74 during a trade that took place back on Aug 14 ’24, which means that Kenneth Stacherski is holding shares at $1,572,774 based on the most recent closing price.
Stock Fundamentals for GEHC
Current profitability levels for the company are sitting at:
- 0.13 for the present operating margin
- 0.41 for the gross margin
The net margin for GE HealthCare Technologies Inc stands at 0.08. The total capital return value is set at 0.11. Equity return is now at value 21.26, with 4.94 for asset returns.
Based on GE HealthCare Technologies Inc (GEHC), the company’s capital structure generated 0.55 points at debt to capital in total, while cash flow to debt ratio is standing at 0.21. The debt to equity ratio resting at 1.2. The interest coverage ratio of the stock is 4.67.
Currently, EBITDA for the company is 3.51 billion with net debt to EBITDA at 2.23. When we switch over and look at the enterprise to sales, we see a ratio of 2.48. The receivables turnover for the company is 4.73for trailing twelve months and the total asset turnover is 0.61. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.01.
Conclusion
In summary, GE HealthCare Technologies Inc (GEHC) has had a mixed performance as of late. Analysts have bullish opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
